1. Fisher AV, Fernandes-Taylor S, Campbell-Flohr SA, Clarkson SJ, Winslow ER, Abbott DE et al. 30-day Readmission After Pancreatic Resection: A Systematic Review of the Literature and Meta-analysis. Ann Surg. 2017;266(2):242-50. doi:https://doi.org/10.1097/sla.0000000000002230.
2. Peluso H, Jones WB, Parikh AA, Abougergi MS. Treatment outcomes, 30-day readmission and healthcare resource utilization after pancreatoduodenectomy for pancreatic malignancies. J Hepatobiliary Pancreat Sci. 2019;26(5):187-94. doi:https://doi.org/10.1002/jhbp.621.
3. Reddy DM, Townsend CM, Jr., Kuo YF, Freeman JL, Goodwin JS, Riall TS. Readmission after pancreatectomy for pancreatic cancer in Medicare patients. J Gastrointest Surg. 2009;13(11):1963–74; discussion 74–5. doi:https://doi.org/10.1007/s11605-009-1006-4.
4. Idrees JJ, Rosinski BF, Merath K, Chen Q, Bagante F, Pawlik TM. Readmission after pancreatic resection: causes, costs and cost-effectiveness analysis of high versus low quality hospitals using the Nationwide Readmission Database. HPB (Oxford). 2019;21(3):291-300. doi:https://doi.org/10.1016/j.hpb.2018.07.011.
5. Medicare program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system and Fiscal Year 2014 rates; quality reporting requirements for specific providers; hospital conditions of participation; payment policies related to patient status. Final rules. Fed Regist. 2013;78(160):50495–1040.